Akish Luintel
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 10%
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- David McCoy (1 shared paper)Jinesh B. Patel (1 shared paper)Gayatri Kembhavi (1 shared paper)Michael Marks (3 shared papers)Arjun J. Nair (1 shared paper)Wai Keong Wong (1 shared paper)Bryan Williams (1 shared paper)Tommy Rampling (1 shared paper)
- Journals
- The Lancet (4 papers)Public Health Action (1 paper)Emerging infectious diseases (1 paper)Clinical Medicine (1 paper)Nature Communications (1 paper)
- Partner nations
- United KingdomEthiopiaNetherlands
In The Last Decade
Akish Luintel
19 papers receiving 1.2k citations
Akish Luintel's Hit Papers
Peers
Comparison fields: 5 of 117
- Infectious Diseases 574
- Neurology 193
- Organizational Behavior and Human Resource Management 81
- Critical Care and Intensive Care Medicine 32
- Obstetrics and Gynecology 40
Countries citing papers authored by Akish Luintel
This map shows the geographic impact of Akish Luintel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akish Luintel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akish Luintel more than expected).
Fields of papers citing papers by Akish Luintel
This network shows the impact of papers produced by Akish Luintel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akish Luintel. The network helps show where Akish Luintel may publish in the future.
Co-authors
The 25 scholars most cited alongside Akish Luintel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 2 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 3 | 2009 | 212 | |
| 4 | 2020 | 194 | |
| 5 | 2020 | 139 | |
| 6 | 2023 | 83 | |
| 7 | 2020 | 34 | |
| 8 | 2020 | 29 | |
| 9 | 2023 | 24 | |
| 10 | 2024 | 23 | |
| 11 | 2017 | 16 | |
| 12 | 2019 | 7 | |
| 13 | 2024 | 6 | |
| 14 | 2025 | 5 | |
| 15 | 2019 | 4 | |
| 16 | 2022 | 3 | |
| 17 | 2019 | 2 | |
| 18 | 2025 | 2 | |
| 19 | 2024 | 1 | |
| 20 | 2019 | 0 |
About Akish Luintel
Akish Luintel is a scholar working on Infectious Diseases, Critical Care and Intensive Care Medicine, Public Health, Environmental and Occupational Health, Neurology and Radiology, Nuclear Medicine and Imaging, having authored 20 papers that have together received 1.3k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), Primary Care and Health Outcomes (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Long-Term Effects of COVID-19 (2 papers), Global Health and Surgery (1 paper), Trypanosoma species research and implications (1 paper), Global Public Health Policies and Epidemiology (1 paper) and COVID-19 diagnosis using AI (1 paper). The work is most often cited by research in Infectious Diseases (574 citations), Neurology (193 citations), Organizational Behavior and Human Resource Management (81 citations), Critical Care and Intensive Care Medicine (32 citations) and Obstetrics and Gynecology (40 citations). Akish Luintel has collaborated with scholars based in United Kingdom, Ethiopia and Netherlands. Frequent co-authors include David McCoy, Jinesh B. Patel, Gayatri Kembhavi, Michael Marks, Arjun J. Nair, Wai Keong Wong, Bryan Williams, Tommy Rampling, Marc C.I. Lipman and Rishi K Gupta. Their work appears in journals such as The Lancet, Public Health Action, Emerging infectious diseases, Clinical Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.